Guided Therapeutics, Inc. (GTHP) Research

Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.

Market snapshot

Symbol
GTHP
Price
$0.29
Day change
0.00%
Market cap
$22.2M
P/E ratio
-6.55x
52-week range
0.123-0.54
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • AccuStem Sciences Limited (ACMSY)
  • Aurora Spine Corporation (ASAPF)
  • Biotricity, Inc. (BTCY)
  • CareView Communications, Inc. (CRVW)
  • Elbit Imaging Ltd. (EMITF)
  • Immunovia AB (publ) (IMMVF)
  • Perimeter Medical Imaging AI, Inc. (PYNKF)
  • United Health Products, Inc. (UEEC)

Recent insider activity

  • Blumberg Richard P. — J-Other (352000 shares) on 2026-03-26
  • Blumberg Richard P. — J-Other (19038 shares) on 2026-03-26
  • Blumberg Richard P. — J-Other (1040000 shares) on 2026-03-26
  • Blumberg Richard P. — J-Other (56093 shares) on 2026-03-26
  • Blumberg Richard P. — M-Exempt (1000000 shares) on 2026-02-25

Open Guided Therapeutics, Inc. (GTHP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.